Ofir Goldberger, Ph.D.
Affiliations: | 2007 | Weizmann Institute of Science, Rehovot, Israel |
Area:
OncologyGoogle:
"Ofir Goldberger"Parents
Sign in to add mentor| Lea Eisenbach | grad student | 2008 | Weizmann Institute | |
| (Adoptive cell transfer for cancer immunotherapy - pitfalls and resolutions.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Bagwell CB, Hunsberger B, Hill B, et al. (2019) Multi-site reproducibility of a human immunophenotyping assay in whole blood and peripheral blood mononuclear cells preparations using CyTOF technology coupled with Maxpar Pathsetter, an automated data analysis system. Cytometry. Part B, Clinical Cytometry |
| Kattah NH, Newell EW, Jarrell JA, et al. (2015) Tetramers reveal IL-17-secreting CD4+ T cells that are specific for U1-70 in lupus and mixed connective tissue disease. Proceedings of the National Academy of Sciences of the United States of America. 112: 3044-9 |
| Volovitz I, Marmor Y, Azulay M, et al. (2011) Split immunity: immune inhibition of rat gliomas by subcutaneous exposure to unmodified live tumor cells. Journal of Immunology (Baltimore, Md. : 1950). 187: 5452-62 |
| Volovitz I, Mor F, Machlenkin A, et al. (2009) T-cell seeding: neonatal transfer of anti-myelin basic protein T-cell lines renders Fischer rats susceptible later in life to the active induction of experimental autoimmune encephalitis. Immunology. 128: 92-102 |
| Goldberger O, Volovitz I, Machlenkin A, et al. (2008) Exuberated numbers of tumor-specific T cells result in tumor escape. Cancer Research. 68: 3450-7 |
| Machlenkin A, Azriel-Rosenfeld R, Volovitz I, et al. (2007) Preventive and therapeutic vaccination with PAP-3, a novel human prostate cancer peptide, inhibits carcinoma development in HLA transgenic mice. Cancer Immunology, Immunotherapy : Cii. 56: 217-26 |
| Machlenkin A, Paz A, Bar Haim E, et al. (2005) Human CTL epitopes prostatic acid phosphatase-3 and six-transmembrane epithelial antigen of prostate-3 as candidates for prostate cancer immunotherapy. Cancer Research. 65: 6435-42 |
| Machlenkin A, Goldberger O, Tirosh B, et al. (2005) Combined dendritic cell cryotherapy of tumor induces systemic antimetastatic immunity. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 11: 4955-61 |
| Lee SH, Bar-Haim E, Goldberger O, et al. (2004) Expression of FasL by tumor cells does not abrogate anti-tumor CTL function. Immunology Letters. 91: 119-26 |
| Lee SH, Bar-Haim E, Machlenkin A, et al. (2004) In vivo rejection of tumor cells dependent on CD8 cells that kill independently of perforin and FasL. Cancer Gene Therapy. 11: 237-48 |